OMEROS CORP Proceeds from Issuance of Debt
OMEROS CORP (OMER) reported Proceeds from Issuance of Debt of $44.55 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2019-03-01
- OMEROS CORP proceeds from issuance of debt for the quarter ending 2011-12-31 was $0.00.
- OMEROS CORP proceeds from issuance of debt for the quarter ending 2011-09-30 was $0.00.
- OMEROS CORP proceeds from issuance of debt for the quarter ending 2011-06-30 was $0.00.
- OMEROS CORP proceeds from issuance of debt for the quarter ending 2011-03-31 was $9.94M.
- OMEROS CORP proceeds from issuance of debt for fiscal 2018 was $44.55M.
- OMEROS CORP proceeds from issuance of debt for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- OMEROS CORP proceeds from issuance of debt for fiscal 2016 was $100.00M, a 100.00% increase from fiscal 2015.
- OMEROS CORP proceeds from issuance of debt for fiscal 2015 was $50.00M, a 56.25% increase from fiscal 2014.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month | Proceeds from Issuance of Debt 12 month as first filed | Proceeds from Issuance of Debt 204 month | Proceeds from Issuance of Debt 207 month |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $44.55M 10-K · filed 2019-03-01 | ||||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 | ||||||
| 2016-12-31 | $100.00M 10-K · filed 2019-03-01 | ||||||
| 2015-12-31 | $50.00M 10-K · filed 2018-03-01 | $22.33M 10-K · filed 2016-03-15 | |||||
| 2014-12-31 | $32.00M 10-K · filed 2017-03-16 | $12.70M 10-K · filed 2015-03-16 | |||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 | ||||||
| 2012-12-31 | $6.49M 10-K · filed 2015-03-16 | ||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $0.00 derived: sum of 2 quarters · filed 2014-03-13 | $0.00 derived: sum of 3 quarters · filed 2014-03-13 | $9.94M 10-K · filed 2014-03-13 | |||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | $9.94M 10-Q · filed 2012-11-09 | $36.61M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $9.94M 10-Q · filed 2012-08-07 | $36.61M 10-Q · filed 2011-08-09 | ||||
| 2011-03-31 | $9.94M 10-Q · filed 2012-05-10 | ||||||
| 2010-12-31 | $9.74M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |